Calithera Biosciences, Inc. Gains 100%
Mon, Jun 03, 2024 at 07:20 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) soared at $0.02, representing a gain of 100%. On Mon, Jun 03, 2024, CALA:NASDAQ touched a New 3-Month Intraday High of $0.12. From Mon, May 20, 2024, the stock recorded 16.67% Up Days and 0.00% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- Avalon GloboCare Corp. (ALBT:NASDAQ), 316.95%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 100%
- Hywin Holdings Ltd. (HYW:NASDAQ), 91.19%
- Affimed N.V. (AFMD:NASDAQ), 68.51%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 61.29%
- Concord Medical Services Holdings Limited (CCM:NYSE), 57.99%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 56.8%
- Structure Therapeutics Inc. (GPCR:NASDAQ), 54.21%
- Histogen Inc. (HSTO:NASDAQ), 45.35%
- Power REIT (PW:NYSEMKT), 39.1%